# Effect of N-acetylcysteine on Oxidative Stress in COVID-19 Patients

> **NCT04792021** · PHASE3 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 60 (actual)

## Conditions studied

- Corona Virus Disease 19 (Covid19)
- Corona Virus Infection
- Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV2)

## Interventions

- **DRUG:** N-acetylcysteine

## Key facts

- **NCT ID:** NCT04792021
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-09
- **Primary completion:** 2021-09-13
- **Final completion:** 2022-04-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04792021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04792021, "Effect of N-acetylcysteine on Oxidative Stress in COVID-19 Patients". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT04792021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*